AbbVie Investor Demands AndroGel Records In Chancery
An AbbVie Inc. investor launched a lawsuit in the Delaware Chancery Court on Friday demanding to see the company's books and records connected to allegations of safety issues with its testosterone...To view the full article, register now.
Already a subscriber? Click here to view full article